Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,018,965
+$700,225 QoQ
Shares Held
2,517
-0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#2,126
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WRIGHT INVESTORS SERVICE INC holds $24,294,827 across 7 Drug Manufacturers - General names. LLY ranks #5 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
55,467 | $7,007,700 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
72,470 | $4,175,720 | |
| 3 | MRK |
Merck & Co., Inc.
|
27,422 | $3,523,727 | |
| 4 | ABBV |
AbbVie Inc.
|
12,739 | $3,205,641 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
2,517 | $3,018,965 | |
| 6 | AMGN |
Amgen Inc
|
7,030 | $2,545,703 | |
| 7 | PFE |
Pfizer Inc
|
33,944 | $817,371 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,018,965 | 2,517 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,318,740 | 2,521 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,981,162 | 2,774 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,123,899 | 1,473 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $2,007,289 | 2,575 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,215,916 | 2,683 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,899,892 | 2,461 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $3,268,232 | 3,689 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $3,339,946 | 3,689 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $2,237,412 | 2,876 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,679,975 | 2,882 | Shares | Sole | 2024-01-31 | |
| No filing history on record for this holder in this stock. | ||||||